#Tsingke_Biotech
LightNews LightNews
newsen.bsky.social
Tsingke Showcases AI-Enabled Antibody Discoveries at AIS 2026 Conference#France#Montpellier#Tsingke_Biotech#CLDN18.2#AIS_2026
Tsingke Showcases AI-Enabled Antibody Discoveries at AIS 2026 Conference
At AIS 2026, Tsingke emphasizes its breakthroughs in AI-assisted antibody discovery, marking significant progress in targeted therapeutics.
third-news.com
July 8, 2026 at 2:40 PM
newsen.bsky.social
Tsingke Biotech and iGeneTech's Partnership to Advance Synthetic Biology Innovations#China#Beijing#Synthetic_Biology#Tsingke_Biotech#iGeneTech
Tsingke Biotech and iGeneTech's Partnership to Advance Synthetic Biology Innovations
Tsingke Biotech and iGeneTech have partnered to advance synthetic biology, aiming for innovations in gene synthesis technology and market expansion.
third-news.com
March 10, 2026 at 3:43 PM
newsen.bsky.social
Tsingke Biotech and iGeneTech Unite to Revolutionize Synthetic Biology Techniques#China#Beijing#Synthetic_Biology#Tsingke_Biotech#iGeneTech
Tsingke Biotech and iGeneTech Unite to Revolutionize Synthetic Biology Techniques
Beijing Tsingke Biotech and iGeneTech are joining forces to innovate synthetic biology through advanced gene synthesis and technology-driven approaches.
third-news.com
March 10, 2026 at 3:43 PM
newsen.bsky.social
Tsingke Biotech Introduces Fast-Track Solutions for Protein and Antibody Development#China#Beijing#Tsingke_Biotech#Antibody_Solutions#Protein_Development
Tsingke Biotech Introduces Fast-Track Solutions for Protein and Antibody Development
At PEGS Europe 2025, Tsingke Biotech showcased groundbreaking technology for rapid protein and antibody development, promising faster drug discovery timelines.
third-news.com
November 19, 2025 at 3:48 PM
newsen.bsky.social
Tsingke Biotech Unveils New Global Website for Enhanced Biotech R&D Services#China#Beijing#Tsingke_Biotech#biotech_services#Gene_Factory
Tsingke Biotech Unveils New Global Website for Enhanced Biotech R&D Services
Beijing Tsingke Biotech has launched its redesigned website to simplify access to global biotech R&D and translational services, enhancing client experiences.
third-news.com
January 20, 2026 at 9:25 AM
newsen.bsky.social
Tsingke Unveils Innovative High-Throughput Workflow for AI-Driven Protein Validation#China#Beijing#Protein_Engineering#Tsingke_Biotech#AI_Proteins
Tsingke Unveils Innovative High-Throughput Workflow for AI-Driven Protein Validation
Tsingke launches a new high-throughput validation process to facilitate the experimental evaluation of AI-designed proteins and antibodies. This advancement accelerates research.
third-news.com
September 22, 2026 at 2:40 PM
newsen.bsky.social
Tsingke Unveils Integrated High-Throughput System for Validating AI-Designed Proteins and Antibodies#China#Beijing#Tsingke_Biotech#AI_Protein_Design#High-Throughput_Validation
Tsingke Unveils Integrated High-Throughput System for Validating AI-Designed Proteins and Antibodies
Tsingke has launched a groundbreaking workflow that enhances the validation of proteins and antibodies designed by AI, streamlining the research process significantly.
third-news.com
September 22, 2026 at 2:39 PM
newsen.bsky.social
Tsingke Biotech Organizes Shanghai Oligonucleotide Drug Salon to Discuss Future of RNA Therapeutics#China#Shanghai#RNA_Therapeutics#Tsingke_Biotech#Oligonucleotide_Drugs
Tsingke Biotech Organizes Shanghai Oligonucleotide Drug Salon to Discuss Future of RNA Therapeutics
Tsingke Biotech hosted an Oligonucleotide Drug Salon in Shanghai, uniting experts to discuss innovations and future pathways in RNA therapeutics.
third-news.com
June 30, 2026 at 2:29 PM
newsen.bsky.social
Tsingke Biotech Illuminates Future of Oligonucleotide Drugs at Shanghai Salon#China#Shanghai#RNA_Therapeutics#Tsingke_Biotech#Oligonucleotides
Tsingke Biotech Illuminates Future of Oligonucleotide Drugs at Shanghai Salon
Tsingke Biotech's recent salon in Shanghai brought together key industry figures to explore innovations in RNA therapeutics and oligonucleotide drugs.
third-news.com
June 30, 2026 at 2:28 PM
newsen.bsky.social
Tsingke Biotech Introduces Innovative 'Zero-Contact' Gene Synthesis System for Enhanced Genetic Security#China#Beijing#Tsingke_Biotech#Gene_Synthesis#Zero-Contact
Tsingke Biotech Introduces Innovative 'Zero-Contact' Gene Synthesis System for Enhanced Genetic Security
Tsingke Biotech has launched its 'Zero-Contact' gene synthesis platform, a groundbreaking step towards safeguarding genetic sequences while ensuring research efficiency.
third-news.com
April 15, 2026 at 2:22 PM
newsen.bsky.social
Tsingke Biotech Introduces Innovative 'Zero-Contact' Gene Synthesis to Enhance Genetic Security#China#Beijing#biotechnology#Tsingke_Biotech#Gene_Synthesis
Tsingke Biotech Introduces Innovative 'Zero-Contact' Gene Synthesis to Enhance Genetic Security
Tsingke Biotech has launched its revolutionary 'Zero-Contact' gene synthesis system, ensuring efficient and secure genetic data management, vital in biotechnology innovation.
third-news.com
April 15, 2026 at 2:22 PM
newsen.bsky.social
Revolutionizing Drug Development: Tsingke Biotech's Breakthrough Protein and Antibody Services#China#Beijing#Drug_Discovery#Tsingke_Biotech#Antibody_Solutions
Revolutionizing Drug Development: Tsingke Biotech's Breakthrough Protein and Antibody Services
Discover how Tsingke Biotech is accelerating drug development with rapid protein and antibody solutions, streamlining the timeline for biopharma companies.
third-news.com
November 19, 2025 at 3:48 PM
newsen.bsky.social
Innovative AI-Driven Biomanufacturing Unveiled by Tsingke Biotech at 2025 Festival#China#Beijing#Tsingke_Biotech#Gene_Synthesis#AI_Biomanufacturing
Innovative AI-Driven Biomanufacturing Unveiled by Tsingke Biotech at 2025 Festival
At the 2025 Festival of Biologics, Tsingke Biotech introduced cutting-edge AI-powered solutions for biomanufacturing, revolutionizing the industry.
third-news.com
October 28, 2025 at 5:36 PM
newsen.bsky.social
Tsingke Biotech Unveils AI-Driven Solutions for Biomanufacturing at Festival of Biologics 2025#China#Beijing#AI_Solutions#Biomanufacturing#Tsingke_Biotech
Tsingke Biotech Unveils AI-Driven Solutions for Biomanufacturing at Festival of Biologics 2025
At the 2025 Festival of Biologics, Tsingke Biotech showcased its innovative AI-driven biomanufacturing solutions, attracting global experts and spotlighting industry trends.
third-news.com
October 28, 2025 at 5:36 PM
newsen.bsky.social
Exploring the Future of RNA-Based Therapeutics: Tsingke Biotech's Roundtable in Beijing#China#Beijing#RNA_Therapeutics#Tsingke_Biotech#Nucleic_Acid_Solutions
Exploring the Future of RNA-Based Therapeutics: Tsingke Biotech's Roundtable in Beijing
Tsingke Biotech recently hosted the 2025 Small Nucleic Acid Therapeutics Roundtable in Beijing, uniting top experts to discuss advances in RNA therapies and their delivery.
third-news.com
July 29, 2025 at 6:35 AM
newsen.bsky.social
Tsingke Biotech Hosts Pivotal Roundtable for Small Nucleic Acid Therapies in Beijing#China#Beijing#RNA_Therapies#Tsingke_Biotech#Nucleic_Acid
Tsingke Biotech Hosts Pivotal Roundtable for Small Nucleic Acid Therapies in Beijing
On July 26, 2025, Tsingke Biotech gathered experts in Beijing to discuss advances in small nucleic acid therapeutics and their commercialization.
third-news.com
July 29, 2025 at 6:34 AM
newsen.bsky.social
Tsingke Biotech Showcases Advanced Oligonucleotide Solutions at TIDES USA 2025#USA#San_Diego#Oligonucleotide_Synthesis#Tsingke_Biotech#TIDES_2025
Tsingke Biotech Showcases Advanced Oligonucleotide Solutions at TIDES USA 2025
Tsingke Biotech marked its presence at TIDES USA 2025, spotlighting innovative oligonucleotide synthesis for therapeutic breakthroughs.
third-news.com
June 5, 2025 at 3:25 AM
newsen.bsky.social
Tsingke Biotech Showcases Innovations in Oligonucleotide Synthesis at TIDES USA 2025#USA#San_Diego#Oligonucleotide_Synthesis#Tsingke_Biotech#GMP_Production
Tsingke Biotech Showcases Innovations in Oligonucleotide Synthesis at TIDES USA 2025
Tsingke Biotech exhibited its advanced oligonucleotide synthesis capabilities at TIDES USA 2025, emphasizing innovations in therapeutic production.
third-news.com
June 5, 2025 at 3:24 AM
newsen.bsky.social
Tsingke Biotech Makes Waves at AACR 2025 with Innovative Cancer Solutions#USA#Chicago#Cancer_Research#AACR_2025#Tsingke_Biotech
Tsingke Biotech Makes Waves at AACR 2025 with Innovative Cancer Solutions
At the AACR Annual Meeting 2025, Tsingke Biotech stands out with its synthesis solutions, vital for advancing cancer research and treatment.
third-news.com
May 15, 2025 at 6:35 AM
newsen.bsky.social
Tsingke Biotech Showcases Innovative Solutions for Cancer Research at AACR 2025#USA#Chicago#Cancer_Research#AACR_Annual_Meeting#Tsingke_Biotech
Tsingke Biotech Showcases Innovative Solutions for Cancer Research at AACR 2025
Tsingke Biotech participated in the AACR Annual Meeting 2025, presenting cutting-edge synthesis solutions crucial for cancer research. The innovations include gene synthesis and protein expression technologies.
third-news.com
May 15, 2025 at 6:23 AM
newsen.bsky.social
Tsingke Gene Innovates with Groundbreaking Calendar Day Delivery Model for Gene Synthesis#China#Beijing#Tsingke_Biotech#Gene_Synthesis#Delivery_Model
Tsingke Gene Innovates with Groundbreaking Calendar Day Delivery Model for Gene Synthesis
In March 2025, Tsingke Gene introduced the revolutionary 'Calendar Day Delivery' model, transforming gene synthesis service standards and delivery times.
third-news.com
April 23, 2025 at 9:26 AM
newsen.bsky.social
Beijing Tsingke Biotech Welcomes Ex-FDA Expert Dr. Yaning Wang to Enhance Small Nucleic Acid Drug Development#China#Beijing#Tsingke_Biotech#Yaning_Wang#small_nucleic_acids
Beijing Tsingke Biotech Welcomes Ex-FDA Expert Dr. Yaning Wang to Enhance Small Nucleic Acid Drug Development
Beijing Tsingke Biotech has appointed former FDA expert Dr. Yaning Wang as Chief Scientific Advisor, boosting small nucleic acid drug innovation.
third-news.com
April 4, 2025 at 1:13 PM
newsen.bsky.social
Beijing Tsingke Biotech Welcomes Dr. Yaning Wang to Lead Their Nucleic Acid Innovation#China#Beijing#Tsingke_Biotech#Yaning_Wang#small_nucleic_acid
Beijing Tsingke Biotech Welcomes Dr. Yaning Wang to Lead Their Nucleic Acid Innovation
Beijing Tsingke Biotech has appointed former FDA expert Dr. Yaning Wang as Chief Scientific Advisor, enhancing their nucleic acid drug development capabilities.
third-news.com
April 4, 2025 at 1:13 PM